Aileron Therapeutics (ALRN) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aileron Therapeutics (NASDAQ:ALRN)CurrentInstitutional OwnershipPercentage90.89%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$11.24MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$55.95K Get ALRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Aileron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALRN Institutional Buying and Selling by Quarter Aileron Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC229,817$814K0.0%+34.8%1.061% 11/4/2024Sigma Planning Corp212,410$752K0.0%+68.3%0.980% 10/29/2024KG&L Capital Management LLC13,000$46K0.0%N/A0.060% 9/17/2024University of Texas Texas AM Investment Management Co.1,777,827$4.93M1.0%N/A8.225% 8/20/2024Nantahala Capital Management LLC464,367$1.29M0.1%+82.1%2.148% 8/9/2024Renaissance Technologies LLC24,864$69K0.0%-44.8%0.115% 8/9/2024Warberg Asset Management LLC31,354$86K0.0%N/A0.145% 8/2/2024University of Texas Texas AM Investment Management Co.1,777,827$4.93M1.9%N/A8.225% 5/13/2024Texas Capital Bank Wealth Management Services Inc26,171$174K0.0%+65.9%0.155% 2/8/2024Texas Capital Bank Wealth Management Services Inc15,773$48K0.0%N/A0.323% Get the Latest News and Ratings for ALRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/1/2024Sigma Planning Corp16,580$51K0.0%N/A0.339% 2/15/2023Alerce Investment Management L.P.830,466$1.97M2.3%-95.0%18.288% 2/10/2023Blair William & Co. IL67,867$161K0.0%-94.5%1.495% 1/31/2023 KCK LTD.22,341$53K0.1%-95.0%0.492% 10/31/2022 KCK LTD.446,817$101K0.2%-30.9%0.492% 4/25/2022Bailard Inc.128,010$66K0.0%N/A0.141% 2/14/2022Blair William & Co. IL1,067,489$601K0.0%+32.9%1.179% 2/11/2022 KCK LTD.646,817$362K0.3%N/A0.714% 2/10/2022Acadian Asset Management LLC85,274$47K0.0%N/A0.094% 2/4/2022Envestnet Asset Management Inc.136,760$77K0.0%+152.4%0.151% 2/2/2022PVG Asset Management Corp50,300$28K0.1%+113.5%0.056% 1/27/2022Morgan Jess S & Co. Inc.100,000$56K0.0%+33.3%0.110% 11/16/2021Keebeck Wealth Management LLC76,000$78K0.0%-51.2%0.084% 11/12/2021Renaissance Technologies LLC734,721$749K0.0%-28.7%0.811% 11/9/2021Morgan Jess S & Co. Inc.75,000$76K0.1%N/A0.083% 11/9/2021Barclays PLC25,279$26K0.0%+235.4%0.028% 11/9/2021JFS Wealth Advisors LLC31,807$32K0.0%N/A0.035% 10/26/2021Game Plan Financial Advisors LLC127,000$130K0.1%+27.0%0.140% 8/17/2021Boothbay Fund Management LLC393,015$491K0.0%+11.8%0.434% 8/16/2021State Street Corp71,200$89K0.0%N/A0.079% 8/13/2021Renaissance Technologies LLC1,031,128$1.29M0.0%-17.5%1.142% 8/13/2021Geode Capital Management LLC766,813$958K0.0%+34.1%0.849% 8/13/2021Vanguard Group Inc.3,440,633$4.30M0.0%-5.9%3.809% 8/12/2021Blair William & Co. IL688,044$860K0.0%+99.1%0.762% 8/4/2021Envestnet Asset Management Inc.34,654$43K0.0%+45.1%0.038% 5/21/2021Citadel Advisors LLC46,830$67K0.0%N/A0.052% 5/19/2021Virtu Financial LLC146,341$209K0.0%+746.6%0.162% 5/18/2021BVF Inc. IL5,265,555$7.53M0.3%N/A5.829% 5/18/2021Citadel Advisors LLC46,830$67K0.0%N/A0.052% 5/17/2021Ikarian Capital LLC2,800,000$4.00M0.1%N/A3.100% Do this Before Elon’s Reveal on January 29th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 5/13/2021Renaissance Technologies LLC1,250,500$1.79M0.0%+97.1%1.385% 5/13/2021Blair William & Co. IL345,594$494K0.0%+29.0%0.383% 5/12/2021Northern Trust Corp127,883$183K0.0%+378.0%0.142% 5/12/2021Geode Capital Management LLC571,738$817K0.0%+149.3%0.633% 5/12/2021Satter Management CO. L.P.16,609,449$23.75M10.5%+118.3%18.394% 5/11/2021Acadian Asset Management LLC134,419$192K0.0%+30.8%0.149% 5/5/2021Wade G W & Inc.100,993$144K0.0%N/A0.112% 5/4/2021Envestnet Asset Management Inc.23,886$34K0.0%+105.2%0.026% 4/28/2021Game Plan Financial Advisors LLC77,500$112K0.1%+13.1%0.086% 2/11/2021Satter Management CO. L.P.7,609,449$7.91M3.1%N/A9.101% 2/10/2021Renaissance Technologies LLC634,381$660K0.0%-47.3%0.759% 2/9/2021Blair William & Co. IL267,994$279K0.0%+10.8%0.321% 2/4/2021GSA Capital Partners LLP86,562$90K0.0%N/A0.198% 1/20/2021Kestra Advisory Services LLC30,000$33K0.0%N/A0.068% (Data available from 1/1/2016 forward) ALRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALRN shares? During the previous two years, 11 institutional investors and hedge funds held shares of Aileron Therapeutics. The most heavily invested institutionals were University of Texas Texas AM Investment Management Co. ($4.93M), Alerce Investment Management L.P. ($1.97M), Nantahala Capital Management LLC ($1.29M), Geode Capital Management LLC ($814K), Sigma Planning Corp ($752K), Texas Capital Bank Wealth Management Services Inc ($174K), and Blair William & Co. IL ($161K).Learn more on ALRN's institutional investors. What percentage of Aileron Therapeutics stock is owned by institutional investors? 90.89% of Aileron Therapeutics stock is owned by institutional investors. Learn more on ALRN's institutional investor holdings. Which institutional investors have been buying Aileron Therapeutics stock? The following institutional investors have purchased Aileron Therapeutics stock in the last 24 months: University of Texas Texas AM Investment Management Co. ($3.56M), Nantahala Capital Management LLC ($209.37K), Sigma Planning Corp ($102.77K), Geode Capital Management LLC ($59.37K), Warberg Asset Management LLC ($31.35K), Texas Capital Bank Wealth Management Services Inc ($26.17K), and KG&L Capital Management LLC ($13K). How much institutional buying is happening at Aileron Therapeutics? Institutional investors have bought a total of 3,997,681 shares in the last 24 months. This purchase volume represents approximately $11.24M in transactions. Which Aileron Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Aileron Therapeutics stock in the last 24 months: Alerce Investment Management L.P. ($15.78M), Blair William & Co. IL ($1.16M), KCK LTD. ($424.48K), and Renaissance Technologies LLC ($20.20K). How much institutional selling is happening at Aileron Therapeutics? Institutional investors have sold a total of 17,382,584 shares in the last 24 months. This volume of shares sold represents approximately $41.20M in transactions. Related Companies Zentalis Pharmaceuticals Major Shareholders Inhibikase Therapeutics Major Shareholders Cybin Major Shareholders Compugen Major Shareholders Cardiff Oncology Major Shareholders Aclaris Therapeutics Major Shareholders Silence Therapeutics Major Shareholders scPharmaceuticals Major Shareholders Alector Major Shareholders Lyell Immunopharma Major Shareholders This page (NASDAQ:ALRN) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aileron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.